Browse Articles

Near-infrared activation of environmentally-friendly gold and silver nanoparticles for unclogging arteries

Gill et al. | Sep 06, 2024

Near-infrared activation of environmentally-friendly gold and silver nanoparticles for unclogging arteries

Coronary artery disease, the leading cause of death worldwide, results from cholesterol build-up in coronary arteries, limiting blood and oxygen flow to the heart. This study investigated the use of gold and silver nanoparticles coated with aspirin and activated by near-infrared light to improve blood flow in a clogged artery model. The nanoparticles increased simulated blood flow rates, demonstrating potential as a less invasive and more targeted treatment for cardiovascular disease.

Read More...

The effects of algaecides on Spirulina major and non-target organism Daphnia magna

Halepete et al. | Oct 09, 2023

The effects of algaecides on <i>Spirulina major</i> and non-target organism <i>Daphnia magna</i>
Image credit: The authors

Algal blooms pose a threat to ecosystems, but the methods used to combat these blooms might harm more than just the algae. Halepete, Graham, and Lowe-Schmahl demonstrate negative effects of anti-algae treatments on a cyanobacterium (Spirulina major), and the water fleas (Daphnia magna) that live alongside these cyanobacteria.

Read More...

Modeling the heart’s reaction to narrow blood vessels

Athulathmudali et al. | May 22, 2023

Modeling the heart’s reaction to narrow blood vessels

Cardiovascular diseases are the largest cause of death globally, making it a critical area of focus. The circulatory system is required to make the heart function. One component of this system is blood vessels, which is the focus of our study. Our work aims to demonstrate the numeric relationship between a blood vessel's diameter and the number of pumps needed to transport blood.

Read More...

Assessing CDK5 as a Nanomotor for Chemotactic Drug Delivery

Jiang et al. | Sep 08, 2022

Assessing CDK5 as a Nanomotor for Chemotactic Drug Delivery

Enzyme chemotaxis is a thermodynamic phenomenon in which enzymes move along a substrate concentration gradient towards regions with higher substrate concentrations and can be used to steer nanovehicles towards targets along natural substrate concentrations. In patients with Alzheimer’s disease, a gradient of tau protein forms in the bloodstream. Tau protein is a substrate of the enzyme CDK5, which catalyzes the phosphorylation of tau protein and can travel using chemotaxis along tau protein gradients to increasing concentrations of tau and amyloid-beta proteins. The authors hypothesized that CDK5 would be able to overcome these barriers of Brownian motion and developed a quantitative model using Michaelis-Menten kinetics to define the necessary parameters to confirm and characterize CDK5’s chemotactic behavior to establish its utility in drug delivery and other applications.

Read More...